|
1.
|
|
10 p, 673.5 KB |
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors : A Retrospective, Multinational, Multicentre Study
/
Torres, Tiago (University of Porto, Portugal) ;
Chiricozzi, Andrea (Università Cattolica del Sacro Cuore, Rome, Italy) ;
Puig Sanz, Lluís (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Lé, Ana Maria (Centro Académico Clínico ICBAS - CHP, Porto, Portugal) ;
Marzano, Angelo Valerio (Università degli Studi di Milano, Italy) ;
Dapavo, Paolo (University of Turin, Italy) ;
Dauden, Esteban (Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa (IIS-IP), Madrid) ;
Carrascosa, Jόse-Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Lazaridou, Elizabeth (Aristotle University School of Medicine, Thessaloniki, Greece) ;
Duarte, Gleison (Instituto Bahiano de Imunoterapias-IBIS, Salvador, Brazil) ;
Carvalho, André V. E. (Hospital Moinhos de Vento, Porto Alegre, Brazil) ;
Romiti, Ricardo (University of São Paulo, Brazil) ;
Rompoti, Natalia (University of Athens, 'A. Sygros' Hospital for Skin and Venereal Diseases, Athens, Greece) ;
Teixeira, Laetitia (Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Portugal) ;
Abreu, Miguel (University of Porto, Portugal) ;
Ippoliti, Elena (Università Cattolica del Sacro Cuore, Rome, Italy) ;
Maronese, Carlo Alberto (Università degli Studi di Milano, Italy) ;
Llamas-Velasco, Mar (Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa (IIS-IP)) ;
Vilarrasa-Rull, Eva (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
del Alcázar, Elena (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Daponte, Athina-Ioanna (Aristotle University School of Medicine, Thessaloniki, Greece) ;
Papoutsaki, Marina (University of Athens, 'A. Sygros' Hospital for Skin and Venereal Diseases, Athens, Greece) ;
Carugno, Andrea (ASST Papa Giovanni XXIII, Bergamo, Italy) ;
Bellinato, Francesco (University Hospital of Verona, Italy) ;
Gisondi, Paolo (University Hospital of Verona, Italy) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
Tuberculosis has a major global impact. Immunocompetent hosts usually control this disease, resulting in an asymptomatic latent tuberculosis infection (LTBI). Because TNF inhibitors increase the risk of tuberculosis reactivation, current guidelines recommend tuberculosis screening before starting any biologic drug, and chemoprophylaxis if LTBI is diagnosed. [...]
2024 -  10.1007/s40257-024-00845-4
American Journal of Clinical Dermatology, Vol. 25, Num. 2 (march 2024) , p. 333-342
|
|
|
2.
|
|
24 p, 525.4 KB |
Elevating the Standard of Care for Patients with Psoriasis : 'Calls to Action' from Epicensus, a Multistakeholder Pan-European Initiative
/
Koren, Jan (EUROPSO, Polzela, Slovenia) ;
Lambert, Jo (Ghent University) ;
Thomsen, Simon F. (University of Copenhagen) ;
McAteer, Helen (Psoriasis Association) ;
Fabbrocini, Gabriella (University of Naples Federico II) ;
Corazza, Valeria (Italian Psoriatic Association Friends of the Corazza Foundation) ;
Jullien, Denis (Lyon-1 University) ;
Augustin, Matthias (University Medical Center Hamburg-Eppendorf) ;
Warren, Richard B. (University of Manchester) ;
de Rie, Menno A. (University of Amsterdam) ;
Lazaridou, Elizabeth (Aristotle University School of Medicine) ;
Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ;
Guillevin, Loïc (Université Paris Descartes) ;
Grosser, Marius (German Psoriasis Association) ;
Boehncke, Wolf-Henning (University of Geneva) ;
Universitat Autònoma de Barcelona
Despite advances in treatment options and the management of patients with psoriasis, considerable unmet needs remain. Our objective was to identify ways to elevate the standard of care for patients with psoriasis by combining the perspectives of three important stakeholders: patients, clinicians and payors, and define 'Calls to Action' designed to achieve the identified changes. [...]
2022 - 10.1007/s13555-022-00846-3
Dermatology and Therapy, december 2022, p. 1-24
|
|
|
3.
|
|
15 p, 1.2 MB |
The global impact of the COVID-19 pandemic on the management and course of chronic urticaria
/
Kocatürk, Emek (Urticaria Center of Reference and Excellence (UCARE). Department of Dermatology. Koç University School of Medicine) ;
Salman, Andaç (Urticaria Center of Reference and Excellence (UCARE). Department of Dermatology. Marmara University School of Medicine) ;
Cherrez-Ojeda, Ivan (Urticaria Center of Reference and Excellence (UCARE). School of Medicine. Universidad de Especialidades Espíritu Santo. Samborondón. Ecuador and RespiraLab) ;
Criado, Paulo Ricardo (UCARE Center) ;
Peter, Jonny (Urticaria Center of Reference and Excellence (UCARE). Division of Allergy and Clinical Immunology. Department of Medicine. University of Cape Town) ;
Comert-Ozer, Elif (Urticaria Center of Reference and Excellence (UCARE). Department of Dermatology. Marmara University School of Medicine) ;
Abuzakouk, Mohamed (Cleveland Clinic Abu Dhabi) ;
Câmara Agondi, Rosana (Universidade São Paulo. Urticaria Center of Reference and Excellence (UCARE)) ;
Al-Ahmad, Mona (Urticaria Center of Reference and Excellence (UCARE). Microbiology Department. Faculty of Medicine. Kuwait University) ;
Altrichter, Sabine (Charité - Universitätsmedizin Berlin) ;
Arnaout, Rand (Urticaria Al Faisal University. King Faisal Specialist Hospital & Research Center) ;
Arruda, Luisa Karla (University of São Paulo. Preto Medical School.) ;
Asero, Riccardo (Urticaria Center of Reference and Excellence (UCARE). Ambulatorio di Allergologia. Clinica San Carlo) ;
Bauer, Andrea (University Hospital Carl Gustav Carus) ;
Ben-Shoshan, Moshe (McGill University Health Center) ;
Bernstein, Jonathan (University of Cincinnati College of Medicine) ;
Bizjak, Mojca (Urticaria Center of Reference and Excellence (UCARE). Division of Allergy. University Clinic of Respiratory and Allergic Diseases Golnik) ;
Boccon-Gibod, Isabelle (Urticaria Center of Reference and Excellence (UCARE). Clinical Immunology/Internal Medicine Department. National Reference Center for Angioedema. Grenoble University Hospital) ;
Bonnekoh, Hanna (Charité - Universitätsmedizin Berlin) ;
Bouillet, Laurence (Urticaria Center of Reference and Excellence (UCARE). Clinical Immunology/Internal Medicine Department. National Reference Center for Angioedema. Grenoble University Hospital) ;
Brzoza, Zenon (Urticaria Center of Reference and Excellence (UCARE). Department of Internal Medicine with Division of Allergology. Institute of Medical Sciences. University of Opole) ;
Busse, Paula (Urticaria Center of Reference and Excellence (UCARE). Division of Clinical Immunology and Allergy. Icahn School at Mount Sinai) ;
Campos, Regis A. (Serviço de Imunologia. Hospital das Clínicas Edgard Santos) ;
Carne, Emily (Urticaria Center of Reference and Excellence (UCARE). University Hospital of Wales) ;
Conlon, Niall (Urticaria Center of Reference and Excellence (UCARE). Department of Immunology. St James's Hospital and Trinity College.) ;
Criado, Roberta Fachini Jardim (Urticaria Center of Reference and Excellence (UCARE). Faculdade de Medicina do ABC (FMABC)) ;
De Souza Lima, Eduardo Magalhães (Urticaria Center of Reference and Excellence. (UCARE). Faculdade de Ciências. Médicas e da Saúde de Juiz de Fora (SUPREMA)) ;
Demir, Semra (Urticaria Center of Reference and Excellence (UCARE). Division of Allergy. Department of Internal Medicine. Istanbul Faculty of Medicine. Istanbul University) ;
Dissemond, Joachim (Urticaria Center of Reference and Excellence (UCARE). Department of Dermatology. Venereology and Allergology. University of Essen) ;
Doğan Günaydın, Sibel (Urticaria Center of Reference and Excellence (UCARE). Department of Dermatology and Venereology. Faculty of Medicine. Hacettepe University) ;
Dorofeeva, Irina (Urticaria Center of Reference and Excellence (UCARE). Department of Allergy and Immunotherapy. Institute of Immunology. FMBA of Russia) ;
Ensina, Luis Felipe (Urticaria Center of Reference and Excellence (UCARE). Division of Allergy. Clinical Immunology and Rheumatology. Department of Pediatrics. Federal University of São Paulo) ;
Ertaş, Ragip (Urticaria Center of Reference and Excellence (UCARE). Department of Dermatology. Kayseri City Education and Research Hospital) ;
Ferrucci, Silvia Mariel (Urticaria Center of Reference and Excellence (UCARE). Ambulatorio di Dermatologia Allergologica e Professionale. Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico) ;
Figueras-Nart, Ignasi (Institut d'Investigació Biomèdica de Bellvitge) ;
Fomina, Daria (I.M. Sechenov First Moscow State Medical University. Department of Allergology and Clinical Immunology) ;
Franken, Sylvie M. (Urticaria Center of Reference and Excellence (UCARE). Department of Dermatology. Amsterdam UMC) ;
Fukunaga, Atsushi (Urticaria Center of Reference and Excellence (UCARE). Division of Dermatology. Kobe University. Graduate School of Medicine) ;
Giménez-Arnau, Ana M 1961- (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Godse, Kiran (Urticaria Center of Reference and Excellence (UCARE). Department of Dermatology. D Y. Patil University School of Medicine) ;
Gonçalo, Margarida (Urticaria Center of Reference and Excellence (UCARE). Centro Hospitalar Universitário Coimbra and Faculty of Medicine. University of Coimbra) ;
Gotua, Maia (Urticaria Center of Reference and Excellence (UCARE. Center of Allergy and Immunology) ;
Grattan, Clive (Guy's and St Thomas' NHS Foundation Trust (Regne Unit)) ;
Guillet, Carole (Urticaria Center of Reference and Excellence (UCARE). Allergy Unit. Department of Dermatology. University Hospital of Zurich) ;
Inomata, Naoko (Urticaria Center of Reference and Excellence (UCARE). Department of Environmental Immuno-Dermatology. Yokohama City University Graduate School of Medicine) ;
Jakob, Thilo (Justus Liebig Universität Giessen) ;
Karakaya, Gul (Urticaria Center of Reference and Excellence (UCARE). School of Medicine. Department of Chest Diseases. Adult Allergy Unit. Hacettepe University) ;
Kasperska-Zając, Alicja (Urticaria Center of Reference and Excellence (UCARE). European Center for Diagnosis and Treatment of Urticaria. Medical University of Silesia) ;
Katelaris, Constance H. (Urticaria Center of Reference and Excellence (UCARE). Immunology & Allergy Unit. Department of Medicine. Campbelltown Hospital) ;
Košnik, Mitja (Urticaria Center of Reference and Excellence (UCARE). Division of Allergy. University Clinic of Respiratory and Allergic Diseases Golnik) ;
Krasowska, Dorota (Urticaria Center of Reference and Excellence (UCARE). Department of Dermatology. Venereology and Pediatric Dermatology. Medical University of Lublin) ;
Kulthanan, Kanokvalai (Urticaria Center of Reference and Excellence (UCARE). Department of Dermatology. Faculty of Medicine Siriraj Hospital. Mahidol University) ;
Kumaran, M.Sendhil (Urticaria Center of Reference and Excellence (UCARE). Department of Dermatology. Postgraduate Institute of Medical Education and Research) ;
Lang, Claudia (Urticaria Center of Reference and Excellence (UCARE). Allergy Unit. Department of Dermatology. University Hospital of Zurich) ;
Larco-Sousa, José Ignacio (Urticaria Center of Reference and Excellence (UCARE)) ;
Lazaridou, Elizabeth (Urticaria Center of Reference and Excellence (UCARE). Second department of Dermatology and Venereology. Aristotle University of Thessaloniki. General Hospital Papageorgiou) ;
Leslie, Tabi Anika (Urticaria Center of Reference and Excellence (UCARE). Department of Dermatology. Royal Free Hospital) ;
Lippert, Undine (Urticaria Center of Reference and Excellence (UCARE. Department of Dermatology. Medical Center of University Goettingen) ;
Calderón llosa, Oscar (Urticaria Center of Reference and Excellence (UCARE). Department of Allergy. SANNA el Golf) ;
Makris, Michael (Urticaria Center of Reference and Excellence (UCARE). Second Department of Dermatology and Venereology. National and Kapodistrian University of Athens. University General Hospital "Attikon") ;
Marsland, Alexander (Urticaria Center of Reference and Excellence (UCARE). Department of Dermatology. The Urticaria Clinic. Salford Royal Foundation Trust. University of Manchester) ;
Medina, Iris V. (Urticaria Center of Reference and Excellence (UCARE). Allergy and Clinical Immunology Department. Centro Médico Vitae. de Julio) ;
Meshkova, Raisa (Urticaria Center of Reference and Excellence (UCARE). Department of Clinical Immunology and Allergology. Smolensk State Medical University) ;
Bastos Palitot, Esther (Urticaria Center of Reference and Excellence (UCARE). Department of Dermatology. Hospital Universitário Lauro Wanderley) ;
Parisi, Claudio A.S. (Urticaria Center of Reference and Excellence (UCARE). Adults and Pediatrics Allergy Unit. Hospital Italiano de Buenos Aires) ;
Pickert, Julia (Urticaria Center of Reference and Excellence (UCARE). Clinical & Experimental Allergology. Department of Dermatology and Allergology. Philipps University Marburg) ;
Ramon, Germán D. (Urticaria Center of Reference and Excellence (UCARE). Instituto de Alergia e Inmunologia del Sur) ;
Rodríguez-Gonzalez, Mónica (Urticaria Center of Reference and Excellence (UCARE). Department of Allergy. Hospital Español de México) ;
Rosario, Nelson (Urticaria Center of Reference and Excellence (UCARE). Federal University of Parana. Rua General Carneiro) ;
Rudenko, Michael (Urticaria Center of Reference and Excellence (UCARE). London Allergy and Immunology Centre) ;
Rutkowski, Krzysztof (Urticaria Center of Reference and Excellence (UCARE). Department of Allergy. Guy's and St Thomas' Hospital NHS Foundation Trust) ;
Sánchez Caraballo, Jorge Mario (Universidad de Antioquía. Department of Pediatrics) ;
Schliemann, Sibylle (Urticaria Center of Reference and Excellence (UCARE). Department of Dermatology. University Hospital Jena) ;
Sekerel, Bulent Enis (Hacettepe University Faculty of Medicine) ;
Serpa, Faradiba S. (Hospital Santa Casa de Misericórdia de Vitória) ;
Serra-Baldrich, E (Institut d'Investigació Biomèdica Sant Pau) ;
Song, Zhiqiang (Army Medical University) ;
Soria, Angèle (Urticaria Center of Reference and Excellence (UCARE). Service de Dermatologie et Allergologie. Hopital Tenon. APHP. Université) ;
Staevska, Maria (Sofia Medical University) ;
Staubach, Petra (University Medical Center Mainz) ;
Tagka, Anna (National and Kapodistrian University of Athens. "A. Syggros" Hospital. Referral Center of Occupational Dermatological Diseases) ;
Takahagi, Shunsuke (Hiroshima University. Graduate School of Biomedical and Health Sciences) ;
Thomsen, Simon Francis (Urticaria Center of Reference and Excellence (UCARE). Department of Dermatology. Bispebjerg Hospital) ;
Treudler, Regina (Leipzig Interdisciplinary Center of Allergology) ;
Vadasz, Zahava (Urticaria Bnai-Zion Medical Center. Technion Faculty of Medicine) ;
Rodrigues Valle, Solange Oliveira (Federal University of Rio de Janeiro. Department of Internal Medicine) ;
Van Doorn, Martijn B.A. (Urticaria Center of Reference and Excellence (UCARE). Department of Dermatology. Erasmus MC) ;
Vestergaard, Christian (Aarhus University Hospital (Aarhus, Dinamarca)) ;
Wagner, Nicola (University of Erlangen) ;
Wang, Dahu (The Second Hospital of HeBei Medical University) ;
Wang, Liangchun (Sun Yat-sen Memorial Hospital) ;
Wedi, Bettina (Hannover Medical School) ;
Xepapadaki, Paraskevi (National and Kapodistrian University of Athens) ;
Yücel, Esra (Istanbul University. Department of Pediatric Allergy and Immunology) ;
Zalewska-Janowska, Anna (Medical University of Lodz) ;
Zhao, Zuotao (Peking University First Hospital) ;
Zuberbier, Torsten (Charité - Universitätsmedizin Berlin) ;
Maurer, Marcus (Charité - Universitätsmedizin Berlin) ;
Universitat Autònoma de Barcelona
Introduction: The COVID-19 pandemic dramatically disrupts health care around the globe. The impact of the pandemic on chronic urticaria (CU) and its management are largely unknown. Aim: To understand how CU patients are affected by the COVID-19 pandemic; how specialists alter CU patient management; and the course of CU in patients with COVID-19. [...]
2021 - 10.1111/all.14687
Allergy, Vol. 76 Núm. 3 (march 2021) , p. 816-830
|
|
|
4.
|
|
10 p, 390.5 KB |
The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa : Results of a prospective European cohort study
/
van Straalen, Kelsey R. (Erasmus MC. University Medical Center Rotterdam. Department of Dermatology) ;
Tzellos, Thrasyvoulos (Department of Dermatology. Nordland Hospital Trust) ;
Guillem, Phillipe (Groupe de Recherche en Proctologie de la Société Nationale Française de ColoProctologie) ;
Benhadou, Farida (Department of Dermatology. Université Libre de Bruxelles. Erasme Hospital) ;
Cuenca-Barrales, Carlos (TECe19-Clinical and Translational Dermatology Investigation Group Instituto de Investigación Biosanitaria) ;
Daxhelet, Mathilde (Department of Dermatology. Université Libre de Bruxelles. Erasme Hospital) ;
Daoud, Mathieu (Department of Dermatology. Université Libre de Bruxelles. Erasme Hospital) ;
Efthymiou, Ourania (Second Department of Dermatology and Venereology. National and Kapodistrian University of Athens. Medical School. "Attikon" General University Hospital) ;
Giamarellos-Bourboulis, Evangelos J. (Fourth Department of Internal Medicine. National and Kapodistrian University of Athens. Medical School) ;
Jemec, Gregor B.E. (Department of Dermatology. Zealand University Hospital. Roskilde and Health Sciences Faculty. University of Copenhagen) ;
Katoulis, Alexandros C. (Second Department of Dermatology and Venereology. National and Kapodistrian University of Athens. Medical School. "Attikon" General University Hospital) ;
Koenig, Anke (Department of Dermatology. Venereology and Allergology. University Hospital Frankfurt am Main) ;
Lazaridou, Elizabeth (Second Department of Dermatology and Venereology. Aristotle University of Thessaloniki. General Hospital Papageorgiou) ;
Marzano, Angelo V. (Department of Pathophysiology and Transplantation. Università degli Studi di Milano) ;
Matusiak, Łucas (Department of Dermatology. Venereology and Allergology. Medical University) ;
Molina-Leyva, Alejandro (TECe19-Clinical and Translational Dermatology Investigation Group Instituto de Investigación Biosanitaria) ;
Moltrasio, Chiara (Department of Medical Surgical and Health Sciences. University of Trieste) ;
Pinter, Andreas (Department of Dermatology. Venereology and Allergology. University Hospital Frankfurt am Main) ;
Potenza, Concetta (Dermatology Unit 'Daniele Innocenzi. ' Department of Medical-Surgical Sciences and Biotechnologies. Sapienza University of Rome) ;
Romaní, Jorge (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Saunte, Ditte M. (Department of Dermatology. Zealand University Hospital. Roskilde and Health Sciences Faculty. University of Copenhagen) ;
Skroza, Nevena (Dermatology Unit 'Daniele Innocenzi. ' Department of Medical-Surgical Sciences and Biotechnologies. Sapienza University of Rome) ;
Stergianou, Dimitra (Fourth Department of Internal Medicine. National and Kapodistrian University of Athens. Medical School) ;
Szepietowski, Jacek (Department of Dermatology. Venereology and Allergology. Medical University) ;
Trigoni, Anastasia (Second Department of Dermatology and Venereology. Aristotle University of Thessaloniki. General Hospital Papageorgiou) ;
Vilarrasa-Rull, Eva (Institut d'Investigació Biomèdica Sant Pau) ;
van der Zee, Hessel H. (Erasmus MC. University Medical Center Rotterdam. Department of Dermatology) ;
Universitat Autònoma de Barcelona
Background: Tetracyclines and clindamycin plus rifampicin combination therapy are both considered first-line therapy in current hidradenitis suppurativa guidelines. However, evidence for their efficacy is drawn from small studies, often without validated outcomes. [...]
2021 - 10.1016/j.jaad.2020.12.089
Journal of the American Academy of Dermatology, Vol. 85 Núm. 2 (august 2021) , p. 369-378
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
